Combined Actions and Interactions of Chemicals in Mixtures

More documents

Recommendations

Info

theoretical considerations and a suggested two-step procedure. Toxicol Lett, 76, 47-55. Feron VJ, Groten JP and van Bladeren PJ (1998). Exposure of humans to complex chemical mixtures: Hazard identification and risk assessment. Arch Toxicol, Suppl. 20, 363-373. Feron VJ and Groten JP (2002). Toxicological evaluation of chemical mixtures. Fd Chem Toxicol, 40(6), 825-839. Finney DJ (1942). The analysis of toxicity tests on mixtures of poisons. Ann Appl Biol, 29, 82-93. Flanagan PR, McLellan JS, Haist J, Cherian G, Chamberlain MJ and Valberg LS (1978). Increased dietary cadmium absorption in mice and human subjects with iron deficiency. Gastroenterology, 74, 841-846. Freeman G, Juhos LT, Furiosi NJ., Mussenden R, Stephends RJ and Evans MJ (1974). Pathology of pulmonary disease from exposure to interdependent ambient gases (nitrogen dioxide and ozone). Arch Environ Health, 29, 203-210. Friedman A, Kaufer D, Shemer J, Hendler I, Soreq H, Tur-Kaspa I (1996). Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nat Med, 12, 1382-1385. Fucic A, Jazbec A, Mijic A, Seso-Simic D and Tomek R (1998). Cytogenetic consequences after occupational exposure to antineoplastic drugs. Mutat Res, 416, 59-66. Fukuda M, Nishio K, Kanzawa F, Ogasawara H, Ishida T, Arioka H, Bojanowski K, Oka M and Saijo N (1996). Synergism between cisplatin and topoisomerase I inhibitors, NB-506 and SN-38, in human small cell lung cancer cells. Cancer Res 56, 789-793. Gaido KW, McDonnel DP, Korach KS and Safe S (1997). Estrogenic activity of chemical mixtures: Is there synergism? CIIT Activities 17, 1-7. Gallagher JE, Jackson MA, George MH and Lewtas J (1990). Dose related differences in DNA adduct levels in rodent tissues following skin application of complex mixtures from air pollution sources. Carcinogenesis, 11, 63-68. Gallagher JE, George M, Kohan M, Thompson C, Shank T and Lewtas J (1993). Detection and comparison of DNA adducts after in vitro and in vivo diesel emission exposures. Environ Health Perspect, 99, 225-228. Galloway SM (1994). Chromosome aberrations induced in vitro: Mechanisms, delayed expression, and intriguing questions. Environ Mol Mutagen, 23 (supplement 24), 44-53. Garewal H (1995). Antioxidants in oral cancer prevention. Am J Clin Nutr, 62, 1410S-1416S. Gargas ML, Medinsky MA and Andersen ME (1993). Advances in physiological modelling approaches for understanding the disposition of inhaled vapors. In Gardner, DE, Crapo, JD and McClellan RO (editors.). Toxicology of the lung. Raven Press, New York, pp. 461-483. 140
Gelb MH, Tamanoi F, Yokoyama K, Ghomashchi F, Esson K and Gould MN (1995). The inhibition of protein prenyltransferases by oxygenated metabolites of limonene and perillyl alcohol. Cancer Lett, 91, 169-175. Gelzleichter TR, Witschi HP and Last JA (1992). Synergistic interaction of nitrogen dioxide and ozone on rat lungs: Acute responses. Toxicol Appl Pharmacol, 116, 1-9. Germolec DR and Luster MI (1994). Immune alterations resulting from exposure to chemical mixtures. In Yang RSH (editor).: Toxicology of Chemical Mixtures. Academic, San Diego, 197-217. Germolec DR, Yang RSH, Ackermann MF, Rosenthal GJ, Boorman GA, Blair P and Luster MI (1989). Toxicology studies of a chemical mixture of 25 groundwater contaminants. II. Immunosuppression in B6C3F1 mice. Fundam Appl Toxicol, 13, 377-87. Giri AK and Lu LJ (1995). Genetic damage and the inhibition of 7,12- dimethylbenz[a]anthracene-induced genetic damage by the phytoestrogens, genistein and daidzein, in female ICR mice. Cancer Lett, 95, 125-133. Golbe L (1998). Parkinson's disease: nature meets nurture. Lancet, 352, 1328-1329. Goldstein BO (1976). Combined exposure to ozone and nitrogen dioxide. Environ Health Perspec, 13, 107-110. Gonsebatt ME, Salazar AM, Montero R, Diaz BF, Yanez L, Gomez H and Ostrosky-Wegman P (1995). Genotoxic monitoring of workers at a hazardous waste disposal site in Mexico. Environ Health Perspect, 103 Suppl 1, 111-113. Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Brown GG and Richardson RJ (1997). Occupational exposures to metals as risk factors for Parkinson's disease. Neurology, 48, 650-658. Gorell JM, Johnson CC, Rybicki BA, Peterson EL and Richardson RJ (1998). The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living. Neurology, 50, 1346-1350. Goyer RA, Cherian MG, Jones MM and Reigart JR (1995). Role of chelating agents for prevention, intervention, and treatment of exposures to toxic metals. Environ Health Perspect, 103, 1048-1052. Grafström RC (1990). In vitro studies of aldehyde effects related to human respiratory carcinogenesis. Mutat Res, 238, 175-184. Graveling RA, Pilkington A, George JPK, Butler MP and Tannahill SN (1999). A review of multiple chemical sensitivity. Occup Environ Med, 56, 73-85. Greenwald P and Kelloff GJ (1996). The role of chemoprevention in cancer control. in Hakama M, Beral V, Buiatti E, Faivre J and Parkin DM (Eds.) Chemoprevention in Cancer Control, IARC Sci Publ, 136, 13-22. Grimme LH, Faust M, Boedeker W and Altenburger R (1996). Aquatic toxicity of chemical substances in combination: still a matter of controversy. Human Ecol Risk Assess, 2, 426-433. 141
Page 1 and 2:
Combined Actions and Interactions o
Page 3 and 4:
Contents CONTENTS 3 PREFACE 6 SAMME
Page 5 and 6:
7.2.4 Test systems 85 7.2.5 In vitr
Page 7 and 8:
Sammenfatning og konklusioner Indle
Page 9 and 10:
er ingen viden om, hvorledes den ko
Page 11 and 12:
estemt biologisk respons (ED10, ED2
Page 13 and 14:
vivo. The COMET-assay in vivo and g
Page 15 and 16:
and antagonistic effects may be see
Page 17 and 18:
1 Introduction Prepared by John Chr
Page 19 and 20:
Table 1.3.1: Classification of comb
Page 21 and 22:
Physicochemical interactions will t
Page 23 and 24:
US EPA (1986) applied the concept o
Page 25 and 26:
2.4 Test strategies to assess combi
Page 27 and 28:
Figure 2.4.3.1. Isobologram of two
Page 29 and 30:
CI = d1 /D1 = 1 In this case the is
Page 31 and 32:
2.5 Toxicological test methods When
Page 33 and 34:
3 General concepts in the risk asse
Page 35 and 36:
NOAEL, this indicates that the subs
Page 37 and 38:
of uncertainty i.e. differences in
Page 39 and 40:
describe toxicities that appears to
Page 41 and 42:
should be estimated for all endpoin
Page 43 and 44:
1,2,3,6,7,8-HxCDF 0.1 1,2,3,7,8,9-H
Page 45 and 46:
shows the pronounced influence of t
Page 47 and 48:
Table 4.3.1 Estimates of carcinogen
Page 49 and 50:
Figure 4.4.1.1. Scheme for safety e
Page 51 and 52:
obvious ranking of individual const
Page 53 and 54:
4.5 Approach for assessment of join
Page 55 and 56:
4.6 Approaches currently used by re
Page 57 and 58:
no internationally accepted procedu
Page 59:
Figure 4.6.3.1 Flow chart of the ri
Page 62 and 63:
octyltin dichloride). A number of a
Page 64 and 65:
stannous chloride and cadmium chlor
Page 66 and 67:
seen in the animals from the 1000x
Page 68 and 69:
c TCTFP = 1,1,2-trichloro-3,3,3-tri
Page 70 and 71:
6 Interactions in toxicokinetics Pr
Page 72 and 73:
once more exposed and the kinetics
Page 74 and 75:
Dermis The dermis consists of a sup
Page 76 and 77:
7.1.3 Ocular irritancy 7.1.3.1 Comp
Page 78 and 79:
Another in vitro test for ocular ir
Page 80 and 81:
lipid peroxidation was observed, wh
Page 82 and 83:
mixture. These interactions may dev
Page 84 and 85:
0.6% of live births in humans. In s
Page 86 and 87:
DNA, and that the cell was capable
Page 88 and 89:
(Sorsa et al. 1994, Myslak & Kosmid
Page 90 and 91: Four inhibitors of DNA topoisomeras
Page 92 and 93: cyclophosphamide-metabolising enzym
Page 94 and 95: Nickel compounds are carcinogenic t
Page 96 and 97: 7.2.8 Conclusion As shown in this r
Page 98 and 99: Since no compounds are known to cau
Page 100 and 101: In a more mechanistic sense, promot
Page 102 and 103: Several inhibitors of tumour promot
Page 104 and 105: Table 7.4.1.1 Overview of in vivo t
Page 106 and 107: analysis was used to predict the hi
Page 108 and 109: interaction of TCDD and retinoic ac
Page 110 and 111: and now includes compounds as diver
Page 112 and 113: Furthermore, the estrogenic effects
Page 114 and 115: Dose of A (arbitrary units) 10 8 6
Page 116 and 117: chance or experimental error. One w
Page 118 and 119: 7.6.2.3 Receptors A receptor is a b
Page 120 and 121: 7.6.5.2 Kindling Kindling is the ph
Page 122 and 123: Science Institute (RSI) have conven
Page 124 and 125: eaction with sulfhydryl groups). Th
Page 126 and 127: 7.7.1.3 Mechanisms of immunotoxicit
Page 128 and 129: tested separately. This is a phenom
Page 130 and 131: In practical life an allergen may b
Page 132 and 133: 8.3 Conference proceedings Proceedi
Page 134 and 135: with combinations of environmental
Page 136 and 137: Boyd MR, Statham CM and Longo NS (1
Page 138 and 139: De Wall EJ, Schuurman HJ and Van Lo
Page 142 and 143: Groten JP, Sinkeldam EJ, Muys T, Lu
Page 144 and 145: Howes D, Guy R, Hadgraft J, Heyling
Page 146 and 147: cytochrome P450 1A2 expressed in Am
Page 148 and 149: Lison D, Carbonnelle P, Mollo L, La
Page 150 and 151: Narotsky MG, Weller EA, Chinchilli
Page 152 and 153: Ramsey JC and Andersen ME (1984). A
Page 154 and 155: Silva E, Rajapakse N and Kortenkamp
Page 156 and 157: Leeuwen FXR, Liem AKD, Nolt C, Pete
Page 158: Wlodarczyk B, Biernacki B, Minta M,
show all

Combined Actions and Interactions of Chemicals in Mixtures

Create successful ePaper yourself

Delete template?

Save as template?